Prevention of chemotherapy-induced left ventricular dysfunction

Prevention of left ventricular dysfunction predominantly induced by anthracyclines and/or trastuzumab still represents a challenge for cardio-oncology today. Indeed, this complication threatens to limit the significant gain in cancer survival achieved to date. Oncology strategies with cumulative dos...

Descripción completa

Detalles Bibliográficos
Autores principales: Bisceglia, Irma, Canale, Maria Laura, Cartoni, Domenico, Matera, Sabrina, Petrolati, Sandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8876299/
https://www.ncbi.nlm.nih.gov/pubmed/35233212
http://dx.doi.org/10.1093/eurheartj/suab085

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8876299/
https://www.ncbi.nlm.nih.gov/pubmed/35233212
http://dx.doi.org/10.1093/eurheartj/suab085

Ejemplares similares